Does postoperative chemotherapy improve overall survival of patients with ypT1-2N0 cancer?

BACKGROUND: Perioperative chemotherapy combined with curative gastrectomy has been increasingly represented the standard therapeutic strategy for resectable gastric cancer (GC). However, it is still unclear whether postoperative chemotherapy has a survival benefit for ypT1-2N0 gastric cancer patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Pengfei, Zhang, Yingjing, Yu, Tian, Jiang, Lin, Kang, Weiming, Liu, Yuqin, Yu, Jianchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793547/
https://www.ncbi.nlm.nih.gov/pubmed/36572874
http://dx.doi.org/10.1186/s12957-022-02881-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793547/
https://www.ncbi.nlm.nih.gov/pubmed/36572874
http://dx.doi.org/10.1186/s12957-022-02881-y

Ejemplares similares